Federal Register #FDA2024N2602

FDA Animal Drug User Fee Educational Conference Announcement

The Food and Drug Administration (FDA) is hosting the third annual Animal Drug User Fee Educational Conference to inform stakeholders about the animal drug approval process. - Government Buyer: - Food and Drug Administration (FDA), Department of Health and Human Services - Event Details: - Educational conference focused on the Animal Drug User Fee Act (ADUFA) Reauthorization (FY 2024-2028) - Topics include regulatory pathways, conditional approval and indexing for minor use/minor species, expanded conditional approval, regulatory flexibility during public health emergencies, animal biotechnology products, and protocol quality best practices - Open to the public, both in person and virtually - Location: - Harvey W. Wiley Federal Building, College Park, MD (in-person) - Virtual attendance option - No products or services are being procured; this is an informational event - Stakeholders are encouraged to submit comments for future conference topics - No OEMs or vendors are referenced

Description

The Food and Drug Administration (FDA) is announcing the third of five annual educational conferences as part of the Animal Drug User Fee Act Reauthorization for FY 2024-2028. The conference aims to provide educational sessions for stakeholders interested in the new animal drug approval process. It will be held on July 7, 2026, from 9 a.m. to 1 p.m. Eastern Time, both in person at the Harvey W. Wiley Federal Building in College Park, MD, and virtually. Topics include regulatory pathways, conditional approval, and veterinary innovation programs. Comments can be submitted at any time, with a request to submit within 90 days after the conference.

View original listing